Basel vs. Liverpool: How the Reds Should Line Up in Champions League Game
Just a few days after a rough 1-1 draw at Anfield in the 223rd Merseyside derby against Everton, courtesy of a late Phil Jagielka stunner, Liverpool will be traveling to Basel for their second game of the Champions League group stage. An otherwise encouraging and much improved performance was on tra ...
My tweets
Mon, 13:17: RT @ InfoResist: В Мариуполе могут действовать диверсанты — штаб обороны http://t.co/bVmlfUJXOo Mon, 13:17: RT @ EuropeanPravda: У Митному союзі сварка через горілку http://t.co/qhQdYwS2d5 Mon, 13:17: RT @ novostidnua: Террористы покинули блок-пост на Мотеле в Донецке http://t.co/YE6xNE7 ...
Apple iPhone 6 and iPhone 6 Plus kicks off in China on October 17
The Chinese regulator approved the iPhone 6 for sale in the country just a few hours ago and Apple has rushed to announce the new generation iPhones' pricing and availability. Apple iPhone 6 and iPhone 6 Plus will become officially available on October 17 in the Apple online and retail stores. The o ...
The Frau's American Experiment
The Frau doesn’t want to write about it because if she writes about it it will become real, but there it is: The Frau is leaving Switzerland. Sort of. Let her explain. Good-bye, Switzerland. Hello, American experiment. A lot of things have happened this year. Great things, like her first book being ...
The Start of our Autumn Break Travels
Krista is loving the “year round schooling” schedule they have in Europe. OVer the year, there are the same amount of holiday weeks as in Canada, but they are much more spread out so there is only a month month summer holiday. So, after having 6 weeks of school, we are off for a 2 week Autumn break. ...
Advanced melanoma: Nivolumab shows signs of superior response rate compared to standard chemotherapy #ESMO14
The monoclonal antibody nivolumab achieves superior response rates and a longer duration of response than standard chemotherapy[1] in patients whose melanoma has progressed after treatment with ipilimumab, according to phase III data presented at the ESMO 2014 Congress in Madrid, Spain. “Previously- ...
